VELCADE (bortezomib) 3.5mg powder for solution for injection

Johnson & Johnson would like to update healthcare professionals on the production difficulties at their specialty contract drug manufacturer's site, Ben Venue Laboratories (BVL), following a potential risk of batch contamination due to the deficiencies in sterility assurance in quality management. As there are alternative sources of VELCADE® available, as a precautionary measure, Johnson & Johnson will be switching product supply from BVL to alternate supplies.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.